KCR acquires project portfolio from Ukraine’s CRO AXIS

KCR, a Poland-based contract research organization (CRO), has recently acquired the whole portfolio of clinical projects from the Ukrainian CRO, AXIS Group.

The acquisition of AXIS trials further strengthens KCR’s presence in Ukraine, making the country the most important location for KCR in the region of the Commonwealth of Independent States (CIS). Financial terms of the transaction were not revealed.

“KCR has a long and successful history of conducting clinical trials in Ukraine since we registered our subsidiary in the country in 2007. With the integration of 15 AXIS projects and almost the entire clinical operations team, we consider KCR as one of the key players in Ukraine in regards to trials execution,” said Mike Jagielski, president and chief executive of KCR, adding: "Ukraine, being the second most populated country in the CIS region, presents a favorable market for conducting clinical studies."